{"entity":{"id":"nct07196410","kind":"trial","name":"KAN-004 for Immune-Related Diarrhea or Colitis","aka":[],"tldr":"A phase 1 trial of KAN-004 run by Centre hospitalier de l'Université de Montréal (CHUM), now recruiting.","summary":"KAN-004 for Immune-Related Diarrhea or Colitis is a phase 1 interventional study registered as NCT07196410 by Centre hospitalier de l'Université de Montréal (CHUM), with 21 participants planned, started 2026-03-01. Conditions recorded: Colitis and Diarrhea Caused by Antitumor Drugs. Interventions recorded: KAN-004.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT07196410","url":"https://clinicaltrials.gov/study/NCT07196410"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["kan-004"],"companies":["kanvas-biosciences"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07196410","phase":"1","setting":"A Phase I Study of KAN-004 in Patients With Immune-Related Diarrhea or Colitis","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","enrolled":21,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07196410/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"kan-004","kind":"drug","name":"KAN-004","route":"/drugs/kan-004/"}],"company":[{"id":"kanvas-biosciences","kind":"company","name":"Kanvas Biosciences","route":"/companies/kanvas-biosciences/"}]}}